Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 312 followers
Latest posts
Last updated about 2 hours ago
Pfizer, Arvinas lose interest in commercializing PROTAC inhibitor, leading to layoffs at the biotech
about 2 hours ago
Having already stripped back their development plans for the estrogen receptor (ER)...
QL Biopharm links once-monthly GLP-1 to incumbent-rivaling weight loss in phase 2
about 2 hours ago
Beijing QL Biopharmaceutical has shared phase 2 data on its once-monthly GLP-1...
Leader of NIH's intramural research program to depart agency
about 2 hours ago
The director of internal research at the National Institutes of Health is...
Roche becomes MASH player via $3.5B deal for 89bio and its phase 3 drug
about 4 hours ago
Roche dived into the metabolic dysfunction-associated steatohepatitis space by agreeing to hand...
ArsenalBio lays off 50% of staff in pivot from early-stage research
about 16 hours ago
One of the top fundraisers of 2024 is halving its workforce about...
Dexcom CEO goes on leave while Insulet taps new CFO
about 21 hours ago
The changes at the diabetes tech companies include Dexcom announcing that outgoing...
Following the Apple Watch’s hypertension clearance, FDA warns public against using unauthorized blood pressure tech and baby monitors
about 21 hours ago
The FDA is warning the public to avoid using unreviewed devices for...
VC Aditum launches cardiovascular biotech, offers Mabwell up to $1B for siRNA asset
about 23 hours ago
California VC firm Aditum Bio is at it again, this time partnering...
J&J's IL-23 drug defeats reigning champ Sotyktu in phase 3 psoriasis trial
about 23 hours ago
After being touted as a potential rival to Bristol Myers Squibb’s reigning...
Regeneron reports phase 3 win in ultra-rare disease, bouncing back to spark race to FDA
about 24 hours ago
Regeneron is racing to regulators after reporting a phase 3 win in...
Lilly rounds out oral GLP-1 weight loss data, posts semaglutide-topping results in diabetes
1 day ago
At this year’s meeting of the European Association for the Study of...
Why Sanofi's R&D chief is 'pretty pragmatic' about a 'mixed' year of clinical development
1 day ago
Sanofi’s head of R&D, Houman Ashrafian, Ph.D., spoke to Fierce days before...